These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37604762)

  • 1. A Plea for the Use of Video-recorded Cystoscopy for Blinded Independent Central Review of Tumor Response in Open-label Non-muscle invasive Bladder Cancer Trials.
    Basile G; Pradere B; Bellmunt J; Rouprêt M; Kamat AM; Seisen T
    Eur Urol Oncol; 2023 Oct; 6(5):453-455. PubMed ID: 37604762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of the intensity of follow-up cystoscopy in patients with high-risk non-muscle-invasive bladder cancer.
    Miyake M; Nishimura N; Nishioka Y; Fujii T; Oda Y; Miyamoto T; Tomizawa M; Shimizu T; Owari T; Ohnishi K; Hori S; Morizawa Y; Gotoh D; Nakai Y; Torimoto K; Tanaka N; Imamura T; Fujimoto K
    Int Urol Nephrol; 2024 Mar; 56(3):827-837. PubMed ID: 37910382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
    Kassouf W; Traboulsi SL; Schmitz-Dräger B; Palou J; Witjes JA; van Rhijn BW; Grossman HB; Kiemeney LA; Goebell PJ; Kamat AM
    Urol Oncol; 2016 Oct; 34(10):460-8. PubMed ID: 27368880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non-muscle-Invasive Bladder Cancer.
    Feiertag N; Barry E; Abramson M; Park JY; Kovac E; Aboumohamed A; Watts K; Sankin A
    Clin Genitourin Cancer; 2023 Apr; 21(2):258-264. PubMed ID: 36621462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
    Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
    J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer.
    Karaoglu I; van der Heijden AG; Witjes JA
    World J Urol; 2014 Jun; 32(3):651-9. PubMed ID: 24166285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III.
    Bach T; Bastian PJ; Blana A; Kaminsky A; Keller S; Knoll T; Lang C; Promnitz S; Ubrig B; Keller T; Qvick B; Burger M;
    World J Urol; 2017 May; 35(5):737-744. PubMed ID: 27578233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.
    Daneshmand S; Schuckman AK; Bochner BH; Cookson MS; Downs TM; Gomella LG; Grossman HB; Kamat AM; Konety BR; Lee CT; Pohar KS; Pruthi RS; Resnick MJ; Smith ND; Witjes JA; Schoenberg MP; Steinberg GD
    Nat Rev Urol; 2014 Oct; 11(10):589-96. PubMed ID: 25245244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cystoscopy in non-muscle-invasive bladder cancer: when and how (rigid or flexible)].
    Cicione A; Cantiello F; Damiano R
    Urologia; 2013; 80 Suppl 21():11-5. PubMed ID: 23559127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches for identifying high-risk non-muscle invasive bladder cancer.
    Sanli O; Lotan Y
    Expert Rev Anticancer Ther; 2018 Mar; 18(3):223-235. PubMed ID: 29359984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
    Burger M; Grossman HB; Droller M; Schmidbauer J; Hermann G; Drăgoescu O; Ray E; Fradet Y; Karl A; Burgués JP; Witjes JA; Stenzl A; Jichlinski P; Jocham D
    Eur Urol; 2013 Nov; 64(5):846-54. PubMed ID: 23602406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal timing for the first cystoscopic follow-up using time-to-treatment initiation analysis of oncologic outcomes in primary non-muscle invasive bladder cancer.
    Kim JS; Lee J; Nguyen TT; Choi SY
    Sci Rep; 2024 Apr; 14(1):8440. PubMed ID: 38600160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
    Lotan Y; Agarwal P; Black P; Dickstein R; Kamat AM; Lee B; Narayan VM; Porten S; Psutka SP; Smith AK; Svatek RS; Williams SB; Woldu S
    Urol Oncol; 2024 Aug; 42(8):223-228. PubMed ID: 38307803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a "second look" matters?
    Shen YJ; Zhu YP; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Zhu Y
    Int Urol Nephrol; 2012 Apr; 44(2):451-7. PubMed ID: 21792663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to Non-Muscle-Invasive Bladder Cancer.
    Slovacek H; Zhuo J; Taylor JM
    Curr Oncol Rep; 2021 Jul; 23(9):105. PubMed ID: 34269918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of blue-light cystoscopy in the management of non-muscle invasive bladder cancer].
    Pignot G
    Prog Urol; 2015 Sep; 25(10):607-15. PubMed ID: 26088583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer.
    Vanneste M; van der Heij B; Christiaansen CE; Berendsen CL; Driessen EJM; Bruins HM
    World J Urol; 2023 Aug; 41(8):2173-2178. PubMed ID: 37328699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic cystoscopy for bladder cancer diagnosis and for NMIBC follow-up: An overview of systematic reviews and meta-analyses.
    Soorojebally Y; Neuzillet Y; Lebret T; Allory Y; Descotes F; Ferlicot S; Kassab-Chahmi D; Lamy PJ; Oudard S; Rébillard X; Roy C; Roumiguié M; Rouprêt M; Audenet F
    Prog Urol; 2023 May; 33(6):307-318. PubMed ID: 37088584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
    Soukup V; Čapoun O; Cohen D; Hernández V; Babjuk M; Burger M; Compérat E; Gontero P; Lam T; MacLennan S; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Yuan Y; Zigeuner R
    Eur Urol; 2017 Nov; 72(5):801-813. PubMed ID: 28457661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.